Vascular Endothelial Growth Factor as Potential Biomarker for COVID-19 Severity.
David JosuttisChristian SchwedlerGuido HeymannDenis GümbelMarc Dominik SchmittnerMarianne KruseBerthold HoppePublished in: Journal of intensive care medicine (2023)
Even though there are several limitations to this retrospective study it revealed that in COVID-19 patients VEGF can contribute to the prediction of necessity of ICU, mortality and the prediction of ARDS, kidney injury or shock. Its use in risk stratification and potential pathogenetic involvement should be further investigated.
Keyphrases
- vascular endothelial growth factor
- sars cov
- endothelial cells
- coronavirus disease
- mechanical ventilation
- intensive care unit
- acute respiratory distress syndrome
- cardiovascular events
- risk factors
- extracorporeal membrane oxygenation
- single cell
- human health
- type diabetes
- risk assessment
- atomic force microscopy
- high resolution
- climate change
- mass spectrometry